Insider Purchases: Inside the Buy

Tag: TurnaroundPlays

Modern-day Helen of Troy holding a Hydro Flask and a plummeting stock chart, standing atop Wall Street ruins with insider traders inside a Trojan horse—symbolizing HELE’s beauty-meets-battle investing story.

Helen of Troy (HELE) — Insider Buys, CFOs Turned CEOs, and a Falling Knife You Might Want to Catch (Carefully)

The CEO and CFO of Helen of Troy just bought shares as the stock plunges 90%. Are we looking at a tragic tale, or a comeback for the ages? We dig into the numbers, leadership shuffle, and Wall Street signals—with humor and historical flair.

Read entire article

Tags: CEO insider buying, CFO Insider Buying, ConsumerGoods, Funanc1alInsiders, Funanc1alInsiderSeries, HELE, Helen of Troy, InsiderBuying, Stocks, TurnaroundPlays, ValueInvesting, WallStreetHumor
Topgolf Callaway Brands logo and golf-themed financial chart, with insider purchase highlights and stock ticker MODG

Topgolf Callaway Brands: Can Investors Score a Double Eagle?

Topgolf Callaway may be down 80% from its highs, but insider buys, institutional backing, and a turnaround plan suggest the comeback tour could be real. ⛳📊

Read entire article

Tags: CEO Buys, CEO insider buying, DIrector Buying, Director Insider Buying, EagleOrBogey, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFun, Funanc1alInvesting, Funanc1alStocks, GolfLife, GolfStocks, InsiderBuying, InstitutionalOwnership, MODG Stock, MODGStock, TopgolfCallaway, TurnaroundPlays, ValueInvesting
Cartoon-style illustration of Ligand Pharmaceuticals' building transforming into a giant molecule, with a Nasdaq bell ringing above and two smiling executives tossing cash into a biotech flask labeled “Royalty Engine.”

Ligand Pharmaceuticals (LGND): In a League of Its Own? Insiders Think So!

Ligand Pharma (LGND) isn’t chasing moonshots—it’s collecting royalties across a sprawling biotech empire. With both the CEO and CFO buying in, and a royalty engine showing 46% revenue growth, insiders may know something. Is this the most compelling quiet biotech turnaround on the Nasdaq?

Read entire article

Tags: BiotechHumor, BiotechInvesting, CEO Buys, CEO insider buying, CEOConfidence, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, ContrarianStocks, Funanc1al, Funanc1al for Investors, Funanc1al Investing, Funanc1alInvesting, InsiderBuys, LGND, LGND Stock, LigandPharma, MoleculeMoney, NasdaqBell, PharmaRoyalties, RoyaltyBiotech, RoyaltyEngine, ScienceStocks, SpeculativeBiotech, TurnaroundPlays, VikingTherapeutics, WallStreetHedgeFunds, ZELSUVMI